The effect of FSH administration with HCG at the time of trigger on IVF cycles outcomes
Phase 2
- Conditions
- Female infertility.Female infertility,unspecifiedN97.9
- Registration Number
- IRCT2017082724512N5
- Lead Sponsor
- Deputy of Research and Technology, Shahid Sadoughi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 152
Inclusion Criteria
Infertile women who candidate for IVF cycles underwent GnRH antagonist protocol
Fresh embryo transfer cycles
Exclusion Criteria
Women with history of endocrine disorders
serum estradiol>2500pg/ml in day of trigger
Intrauterine abnormality (uterine polyp; uterine myoma)
Severe male factor
Cycle cancellation or changing to intrauterine insemination
A cycle containing preimplantation genetic diagnosis (PGD)
Women who did not undergo embryo transfer due to the freeze-all policy
Donor or surrogate cycle
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemical pregnancy. Timepoint: 14 days after transfer. Method of measurement: BHCG test.;Clinical pregnancy. Timepoint: 2 weeks after positive BHCG. Method of measurement: Transvaginal sonography.
- Secondary Outcome Measures
Name Time Method Fertilization proportion. Timepoint: Post oocyte retrival. Method of measurement: The number of fertilized oocytes divided by the total number of oocytes.;Oocyte recovery rate. Timepoint: After oocyte retrieval. Method of measurement: The number of retrieved oocytes divided by the number of follicles >10 mm in size counted on the day of trigger.;Oocyte maturity rate. Timepoint: After oocyte retrieval. Method of measurement: the number of metaphase II (MII) oocytes divided by the number of oocytes retrieved.;Fertilization rate. Timepoint: After formation of 2PNs. Method of measurement: the number of 2PNs divided by the total number of MII oocytes.;Implantation rate. Timepoint: After detection of gestational sac in ultrasonography. Method of measurement: the number of intrauterine gestational sacs observed by transvaginal ultrasonography divided by the total number of transferred embryos.